83 results
Page 2 of 5
6-K
EX-99.1
4wqbg5lyvdy7j
17 Nov 21
Jyseleca®▼(filgotinib) approved in the European Union for the treatment of ulcerative colitis
6:00am
6-K
EX-99.2
tzd10astq
8 Nov 21
Galapagos reports commercial and operational progress at Q3 financial results
4:03pm
S-8
EX-99.1
epenzsfjx4wj9 n5
26 Oct 21
Registration of securities for employees
4:07pm
S-8
EX-99.2
7g1 2cl7vy38
26 Oct 21
Registration of securities for employees
4:07pm
S-8
EX-99.3
r3vp8a6dc4sx
26 Oct 21
Registration of securities for employees
4:07pm
6-K
EX-99.2
n7p40uhp7297xi549sd
5 Aug 21
Galapagos reports H1 financial results with refocused pipeline and operational progress
4:02pm
6-K
EX-99.1
h1v6955wfl5a
19 May 21
Current report (foreign)
6:00am
6-K
EX-99.2
0uuj 04o5rw4ov9kt
11 May 21
Current report (foreign)
2:10pm
6-K
EX-99.3
a7ibmsgt9so85
11 May 21
Current report (foreign)
2:10pm
6-K
EX-99.2
s08s4iq1f5pin
25 Mar 21
Publication of the annual report and invitation to the The annual report for the financial year 2020, including a review of figures and performance, is available online at
12:00am
6-K
EX-99.1
7ammxxland
24 Nov 20
Selvita to acquire Fidelta from Galapagos
7:05am
6-K
EX-99.2
eb4gshhwapclfz95i
9 Nov 20
Galapagos reports Q3 2020 results
4:01pm
6-K
EX-99.1
elkbjt8v8
13 Oct 20
Current report (foreign)
6:15am
S-8
EX-99.1
mzhxrvcfg9hachlm2
9 Oct 20
Registration of securities for employees
4:32pm